Dr. Barbieri recaps his presentation from the acne symposium at AAD 2022, in which he provided guidance on managing patient labs and discussed adjuvant therapies to reduce mucocutaneous dryness and initial acne flares in patients being treated with isotretinoin.

AAD 2022 Meeting Coverage
Dr. Desai discusses his AAD 2022 presentation, which focused on a variety of new non-hydroquinone